We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
With the J.P. Morgan Healthcare Conference now over, some analysts are looking back and picking out the “winners and losers” from the conference. CNBC’s Jim Cramer made his picks related to stock performance.
Plenty of companies had interesting news to share at the J.P. Morgan Healthcare Conference in San Francisco this week, and bluebird bio received more attention than some
The J.P. Morgan Healthcare Conference is a yearly opportunity for the biopharma industry to make major announcements and let analysts, investors and the media pick the brains of top execs